Ji, X.* ; Mukherjee, S.* ; Landi, M.T.* ; Bosse, Y.* ; Joubert, P.* ; Zhu, D.* ; Gorlov, I.* ; Xiao, X.* ; Han, Y.* ; Gorlova, O.* ; Hung, R.J.* ; Brhane, Y.* ; Carreras-Torres, R.* ; Christiani, D.C.* ; Caporaso, N.* ; Johansson, M.* ; Liu, G.* ; Bojesen, S.E.* ; Le Marchand, L.* ; Albanes, D.* ; Bickeböller, H.* ; Aldrich, M.C.* ; Bush, W.S.* ; Tardón, A.* ; Rennert, G.* ; Chen, C.* ; Byun, J.* ; Dragnev, K.H.* ; Field, J.K.* ; Kiemeney, L.F.* ; Lazarus, P.* ; Zienolddiny, S.* ; Lam, S.* ; Schabath, M.B.* ; Andrew, A.S.* ; Bertazzi, P.A.* ; Pesatori, A.C.* ; Diao, N.* ; Su, L.* ; Song, L.* ; Zhang, R.* ; Leighl, N.* ; Johansen, J.S.* ; Mellemgaard, A.* ; Saliba, W.* ; Haiman, C.* ; Wilkens, L.* ; Fernández-Somoano, A.* ; Fernandez-Tardon, G.* ; Heijden, E.H.F.M.v.d.* ; Kim, J.H.* ; Davies, M.P.A.* ; Marcus, M.W.* ; Brunnström, H.* ; Manjer, J.* ; Melander, O.* ; Müller, D.C.* ; Overvad, K.* ; Trichopoulou, A.* ; Tumino, R.* ; Goodman, G.E.* ; Cox, A.* ; Taylor, F.* ; Woll, P.* ; Wichmann, H.-E. ; Muley, T.* ; Risch, A.* ; Rosenberger, A.* ; Grankvist, K.* ; Shepherd, F.A.* ; Tsao, M.S.* ; Arnold, S.M.* ; Haura, E.B.* ; Bolca, C.* ; Holcatova, I.* ; Janout, V.* ; Kontic, M.* ; Lissowska, J.* ; Mukeria, A.* ; Ognjanovic, S.* ; Orlowski, T.M.* ; Scelo, G.* ; Swiatkowska, B.* ; Zaridze, D.* ; Bakke, P.* ; Skaug, V.* ; Butler, L.M.* ; Offit, K.* ; Srinivasan, P.* ; Bandlamudi, C.* ; Hellmann, M.D.* ; Solit, D.B.* ; Robson, M.E.* ; Rudin, C.M.* ; Stadler, Z.K.* ; Taylor, B.S.* ; Berger, M.F.* ; Houlston, R.* ; McLaughlin, J.*
Protein-altering germline mutations implicate novel genes related to lung cancer development.
Nat. Commun. 11:2220 (2020)
Few germline mutations are known to affect lung cancer risk. We performed analyses of rare variants from 39,146 individuals of European ancestry and investigated gene expression levels in 7,773 samples. We find a large-effect association with an ATM L2307F (rs56009889) mutation in adenocarcinoma for discovery (adjusted Odds Ratio=8.82, P=1.18x10(-15)) and replication (adjusted OR=2.93, P=2.22x10(-3)) that is more pronounced in females (adjusted OR=6.81 and 3.19 and for discovery and replication). We observe an excess loss of heterozygosity in lung tumors among ATM L2307F allele carriers. L2307F is more frequent (4%) among Ashkenazi Jewish populations. We also observe an association in discovery (adjusted OR=2.61, P=7.98x10(-22)) and replication datasets (adjusted OR=1.55, P=0.06) with a loss-of-function mutation, Q4X (rs150665432) of an uncharacterized gene, KIAA0930. Our findings implicate germline genetic variants in ATM with lung cancer susceptibility and suggest KIAA0930 as a novel candidate gene for lung cancer risk. In lung cancer, relatively few germline mutations are known to impact risk. Here the authors looked at rare variants in 39,146 individuals and find novel germline mutations associated with risk, as well as implicating ATM and a new candidate gene for lung cancer risk.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Association; Susceptibility; Expression; Prediction; Brca1
Keywords plus
Language
english
Publication Year
2020
Prepublished in Year
HGF-reported in Year
2020
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 11,
Issue: 1,
Pages: ,
Article Number: 2220
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Institute of Epidemiology (EPI)
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-504000-009
Grants
Copyright
Erfassungsdatum
2020-06-08